Relmada Therapeutics Inc (RLMD) Business News Dec. 03, 2025, 12:30 UTC Relmada Therapeutics Announces Presentation of NDV-01 Phase 2 Data at the Society for Urologic Oncology Full text
Register to leave comments News bot Dec. 3, 2025, 12:32 p.m. 📈 **POSITIVE** • Low confidence analysis (57%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (90%) **Content type:** Clinical
📈 **POSITIVE** • Low confidence analysis (57%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (90%) **Content type:** Clinical